Tag: Eurobio
Eurobio Scientific: 2023 results down, the stock falls
(CercleFinance.com) – Eurobio Scientific revealed yesterday evening declining results for the 2023 financial year, but set itself the objective of returning to growth in its turnover and its margins. Penalized…
Eurobio Scientific: deterioration of its accounts in 2023 – 04/10/2024 at 6:20 p.m.
(AOF) – Eurobio Scientific records a turnover of 130 million euros for the 2023 financial year, down 17%. The gross operating margin rate, before the non-recurring effect of the sale…
Eurobio Scientific: deterioration of its accounts in 2023
(AOF) – Eurobio Scientific records a turnover of 130 million euros for the 2023 financial year, down 17%. The gross operating margin rate, before the non-recurring effect of the sale…
Eurobio: annual sales of 130.1 ME
resume Published on 01/30/2024 at 5:55 p.m. Photo credit © ChaunuPictures (Boursier.com) — Eurobio Scientific recorded…
Eurobio Scientific makes progress in 2023 on its core business
(AOF) – Eurobio Scientific published 2023 turnover up 39% to 130.1 million euros for its core business. It increased by 12% like-for-like. The specialist in in vitro medical diagnostics and…
Eurobio Scientific is making progress in 2023 on its core business – 01/30/2024 at 6:22 p.m.
(AOF) – Eurobio Scientific published 2023 turnover up 39% to 130.1 million euros for its core business. It increased by 12% like-for-like. The specialist in in vitro medical diagnostics and…
Eurobio Scientific cancels 694,300 shares or 6.34% of its capital
(AOF) – Eurobio Scientific announces that it has today canceled 694,300 treasury shares, representing 6.34% of the share capital, in accordance with the authorization given by the general meeting of…
Eurobio Scientific: cancellation of treasury shares – 01/10/2024 at 2:48 p.m.
Member Login Customer Login (CercleFinance.com) – The specialty in vitro medical diagnostics company Eurobio Scientific announces that it has canceled 694,300 treasury shares, representing 6.34% of the share capital, a…
Eurobio scientific: The diagnostics group Eurobio Scientific negotiates the post-Covid situation without a hitch
(BFM Bourse) – The in vitro diagnostics specialist published half-yearly accounts better than expected, supported by the ramp-up of its core activities. This makes it possible to take over from…
Eurobio Scientific: half-year sales up 7% on a comparable basis, excluding Covid – 07/24/2023 at 18:08
(AOF) – Eurobio Scientific announces for the 1st half of 2023 a turnover of 59.1 million euros on its core business. The group specializing in in vitro medical diagnostics and…
Eurobio Scientific: half-year sales up 7% on a comparable basis, excluding Covid
(AOF) – Eurobio Scientific announces for the 1st half of 2023 a turnover of 59.1 million euros on its core business. The group specializing in in vitro medical diagnostics and…
Eurobio Scientific: new governance
By Alexandra Saintpierre Published on 06/19/2023 at 07:14 Photo credit © ChaunuPictures (Boursier.com) — Eurobio Scientific held the…